Pernille Tine Jensen

Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Andreas Du Bois
  • ,
  • Ignace Vergote
  • ,
  • Gwenael Ferron
  • ,
  • Alexander Reuss
  • ,
  • Werner Meier
  • ,
  • Stefano Greggi
  • ,
  • Pernille Tina Jensen
  • Frededric Selle
  • ,
  • Frederic Guyon
  • ,
  • Christophe Pomel
  • ,
  • Fabrice Lecuru
  • ,
  • Rongyu Zang
  • ,
  • Elisabeth Avall-Lundqvist
  • ,
  • Jae Weon Kim
  • ,
  • Jordi Ponce
  • ,
  • Francesco Raspagliesi
  • ,
  • Sadaf Ghaem-Maghami
  • ,
  • Alexander Reinthaller
  • ,
  • Philipp Harter
  • ,
  • Jalid Sehouli
OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind35
Antal sider5
ISSN0732-183X
DOI
StatusUdgivet - 20 maj 2017
Begivenhed53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET - Chicago, Israel
Varighed: 2 jun. 20177 jun. 2017

Konference

Konference53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET
LandIsrael
ByChicago
Periode02/06/201707/06/2017

Se relationer på Aarhus Universitet Citationsformater

ID: 178481636